1. Home
  2. KZIA vs WKHS Comparison

KZIA vs WKHS Comparison

Compare KZIA & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • WKHS
  • Stock Information
  • Founded
  • KZIA 1994
  • WKHS 2007
  • Country
  • KZIA Australia
  • WKHS United States
  • Employees
  • KZIA N/A
  • WKHS N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • WKHS Auto Manufacturing
  • Sector
  • KZIA Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • KZIA 5.1M
  • WKHS 6.0M
  • IPO Year
  • KZIA 1999
  • WKHS N/A
  • Fundamental
  • Price
  • KZIA $6.10
  • WKHS $1.14
  • Analyst Decision
  • KZIA Strong Buy
  • WKHS Hold
  • Analyst Count
  • KZIA 2
  • WKHS 1
  • Target Price
  • KZIA $57.50
  • WKHS $15.62
  • AVG Volume (30 Days)
  • KZIA 2.6M
  • WKHS 510.7K
  • Earning Date
  • KZIA 07-07-2025
  • WKHS 08-19-2025
  • Dividend Yield
  • KZIA N/A
  • WKHS N/A
  • EPS Growth
  • KZIA N/A
  • WKHS N/A
  • EPS
  • KZIA N/A
  • WKHS N/A
  • Revenue
  • KZIA $1,549,158.00
  • WKHS $5,917,985.00
  • Revenue This Year
  • KZIA N/A
  • WKHS $54.16
  • Revenue Next Year
  • KZIA N/A
  • WKHS $85.00
  • P/E Ratio
  • KZIA N/A
  • WKHS N/A
  • Revenue Growth
  • KZIA 248983.08
  • WKHS N/A
  • 52 Week Low
  • KZIA $2.86
  • WKHS $0.81
  • 52 Week High
  • KZIA $79.00
  • WKHS $28.13
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 50.96
  • WKHS 58.99
  • Support Level
  • KZIA $5.83
  • WKHS $0.93
  • Resistance Level
  • KZIA $9.60
  • WKHS $1.20
  • Average True Range (ATR)
  • KZIA 1.19
  • WKHS 0.09
  • MACD
  • KZIA -0.29
  • WKHS 0.03
  • Stochastic Oscillator
  • KZIA 18.39
  • WKHS 79.08

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: